Central Nervous System Involvement as Outcome Measure for Clinical Trials Efficacy in Myotonic Dystrophy Type 1

Overview of attention for article published in Frontiers in Neurology, October 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 2 news outlets

twitter: 6 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 61 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Enfermedad de Steinert, ¿cambio de paradigma?

Gaceta Medica, 07 Jul 2023

Alfredo Rosado Bartolomé La distrofia miotónica de tipo 1 (DM1 o enfermedad de Steinert) es un trastorno autosómico dominante…

Central Nervous System Involvement as Outcome Measure for Clinical Trials Efficacy in Myotonic Dystrophy Type 1

MyNeuroNews, 07 Oct 2020

Increasing evidences indicate that in Myotonic Dystrophy type 1 (DM1 or Steinert disease), an autosomal dominant multisystem…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.